GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $3.79 $5.28 Thursday, 18th Apr 2024 AVXL stock ended at $3.80. This is 6.63% less than the trading day before Wednesday, 17th Apr 2024. During the day the stock fluctuated 7.65% from a day low at $3.79 to a day high of $4.08.
90 days $3.79 $6.90
52 weeks $3.79 $10.31

Historical Anavex Life Sciences Corp. prices

Date Open High Low Close Volume
2024-04-18 $4.05 $4.08 $3.79 $3.80 1 632 363
2024-04-17 $4.20 $4.20 $4.02 $4.07 1 333 696
2024-04-16 $4.15 $4.19 $4.06 $4.12 1 249 889
2024-04-15 $4.31 $4.36 $4.18 $4.23 1 073 120
2024-04-12 $4.41 $4.47 $4.16 $4.30 1 126 756
2024-04-11 $4.30 $4.50 $4.30 $4.45 802 136
2024-04-10 $4.23 $4.30 $4.17 $4.29 1 401 440
2024-04-09 $4.40 $4.45 $4.29 $4.39 975 192
2024-04-08 $4.47 $4.50 $4.34 $4.39 858 257
2024-04-05 $4.45 $4.52 $4.34 $4.42 1 112 864
2024-04-04 $4.69 $4.70 $4.46 $4.48 1 502 289
2024-04-03 $4.52 $4.76 $4.46 $4.62 1 076 866
2024-04-02 $4.85 $4.87 $4.52 $4.54 1 460 588
2024-04-01 $5.08 $5.08 $4.88 $5.02 819 542
2024-03-28 $5.04 $5.20 $4.98 $5.09 978 026
2024-03-27 $4.91 $5.11 $4.80 $5.06 916 016
2024-03-26 $4.66 $5.03 $4.62 $4.84 1 319 661
2024-03-25 $4.65 $4.70 $4.48 $4.55 1 354 429
2024-03-22 $5.05 $5.07 $4.63 $4.66 1 286 799
2024-03-21 $5.19 $5.28 $5.10 $5.11 1 067 155
2024-03-20 $4.83 $5.12 $4.82 $5.12 974 372
2024-03-19 $4.85 $4.92 $4.80 $4.84 1 523 838
2024-03-18 $5.11 $5.15 $4.81 $4.82 1 484 302
2024-03-15 $5.09 $5.28 $5.08 $5.11 6 456 596
2024-03-14 $5.34 $5.35 $5.09 $5.14 1 188 165
Click to get the best stock tips daily for free!

About Anavex Life Sciences Corp.

Anavex Life Sciences . Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patients with Rett syndrome; Phase II clinical trial for the treatment of Parkinson's disease; and preclinica... AVXL Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT